We are live on ! Find out more
NVPX

Norwest Venture Partners XII Portfolio holdings

AUM $75.4M
1-Year Est. Return 53.35%
This Fund
S&P 500
This Quarter Est. Return
+31.29%
1 Year Est. Return
-53.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86M
AUM Growth
+$77.7M
Cap. Flow
+$65M
Cap. Flow %
75.56%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HCAT icon
Health Catalyst
HCAT
+$65M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.76%
2 Consumer Discretionary 20.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCAT icon
1
Health Catalyst
HCAT
$160M
$68.6M 79.76%
+2,352,090
New +$65M
CSPR
2
DELISTED
Casper Sleep Inc.
CSPR
$17.4M 20.24%
1,940,576
– –

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

Norwest Venture Partners XII's Q2 2020 Portfolio in Review

As of Q2 2020, Norwest Venture Partners XII held 2 positions worth $86M, up 933% from $8.32M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Norwest Venture Partners XII deployed $65M of net new capital in Q2 2020, opening 1 new position. Its largest new stake was Health Catalyst: 2,352,090 shares worth $68.6M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 0% a quarter earlier, followed by Consumer Discretionary.

  • Norwest Venture Partners XII's largest Q2 2020 buy was Health Catalyst: 2,352,090 shares worth $68.6M.
  • Norwest Venture Partners XII's ten largest holdings make up 100% of its $86M portfolio in Q2 2020.
  • Norwest Venture Partners XII opened 1 new position and closed 0 in Q2 2020.
  • Norwest Venture Partners XII's portfolio value rose 933% quarter-over-quarter to $86M.

Based on Norwest Venture Partners XII's 13F filing for Q2 2020, filed 14 Jul 2020.